Response to first-line chemotherapy and sensitivity to epidermal growth factor receptor (EGFR) inhibitors in advanced non-small-cell lung cancer (NSCLC) patients

被引：0
|
作者：
Betti, Maura
Toschi, L.
Metro, G.
Bartolini, Stefania
Magrini, E.
de Angelis, Verena
Chiari, Rita
Ferraldeschi, Massimiliano
Cappuzzo, Federico
Crino, Lucio
机构：
[1] Osped Silvestrini, Perugia, Italy
[2] Univ Bologna, Osped Bellaria, Ist Anat & Istol Patol, I-40139 Bologna, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：235 / 235
页数：1
相关论文
共 50 条
  • [1] Mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) and response to first-line erlotinib in advanced non-small-cell lung cancer (NSCLC) patients (p)
    Reguart-Aransay, Noemi
    Mayo, Clara
    Queralt, Cristina
    Botia, Monica
    Pastor, Carmen
    Perez, Maria
    Catot, Silvia
    Prada, Anna
    Galvez, Marc
    Taron, Miquel
    Rosell, Rafael
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [2] First-Line Gefitinib for Patients With Advanced Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy
    Inoue, Akira
    Kobayashi, Kunihiko
    Usui, Kazuhiro
    Maemondo, Makoto
    Okinaga, Shoji
    Mikami, Iwao
    Ando, Masahiro
    Yamazaki, Koichi
    Saijo, Yasuo
    Gemma, Akihiko
    Miyazawa, Hitoshi
    Tanaka, Tomoaki
    Ikebuchi, Kenji
    Nukiwa, Toshihiro
    Morita, Satoshi
    Hagiwara, Koichi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (09) : 1394 - 1400
  • [3] Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
    O'Leary, Connor
    Gasper, Harry
    Sahin, Katherine B.
    Tang, Ming
    Kulasinghe, Arutha
    Adams, Mark N.
    Richard, Derek J.
    O'Byrne, Ken J.
    [J]. PHARMACEUTICALS, 2020, 13 (10) : 1 - 16
  • [4] Evaluation of epidermal growth factor receptor (EGFR) as a prognostic factor for survival in non-small-cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy as first-line treatment.
    Janas, M
    Bailey, LR
    Schmidt, K
    Bindslev, N
    Wolf, M
    Fandi, A
    Askaa, J
    Herbst, R
    Giaccone, G
    Johnson, DH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 622S - 622S
  • [5] EGFR inhibitors as the first-line systemic treatment for advanced non-small-cell lung cancer
    Kao, Hsiang-Fong
    Lin, Chia-Chi
    Yang, James Chih-Hsin
    [J]. FUTURE ONCOLOGY, 2013, 9 (07) : 991 - 1003
  • [6] Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors as a first-line treatment for postoperative recurrent and EGFR-mutated non-small-cell lung cancer
    Moriya, Tetsuji
    Hamaji, Masatsugu
    Yoshizawa, Akihiko
    Miyata, Ryo
    Noguchi, Misa
    Tamari, Shigeyuki
    Chiba, Naohisa
    Miyamoto, Hideaki
    Toyazaki, Toshiya
    Tanaka, Satona
    Yamada, Yoshito
    Yutaka, Yojiro
    Nakajima, Daisuke
    Ohsumi, Akihiro
    Menju, Toshi
    Date, Hiroshi
    [J]. INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2022, 34 (03) : 416 - 423
  • [7] Response to First-Line Chemotherapy in Patients With Non-Small-Cell Lung Cancer According to Epidermal Growth Factor Receptor and K-RAS Mutation Status
    Dong, Xiaopeng
    Zhao, Xiaogang
    Hao, Yingtao
    Wei, Yucheng
    Yin, Qiuwei
    Du, Jiajun
    [J]. CLINICAL LUNG CANCER, 2013, 14 (06) : 680 - 687
  • [8] Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors combined with chemotherapy in first-line treatment in an advanced non-small cell lung cancer patient with EGFR sensitive mutation
    Huang, Aimi
    Li, Rong
    Zhao, Jikai
    Wang, Xiaofei
    Jin, Bo
    Niu, Yanjie
    Zhang, Jie
    Jiang, Liyan
    Han, Baohui
    [J]. THORACIC CANCER, 2016, 7 (05) : 614 - 618
  • [9] Epidermal growth factor receptor (EGFR) mutation testing and first-line treatment with gefitinib as a strategy in the treatment of patients with advanced non-small cell lung cancer (NSCLC).
    Lopes, G.
    Segel, J.
    Tan, D. S. W.
    Do, Y.
    Mok, T.
    Finkelstein, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer
    Lee, Kyung-Hun
    Han, Sae-Won
    Hwang, Pil Gyu
    Oh, Do-Youn
    Kim, Dong-Wan
    Chung, Doo Hyun
    Im, Seock-Ah
    Kim, Tae-You
    Heo, Dae Seog
    Bang, Yung-Jue
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (06) : 344 - 350
12345